6-carboxyfluorescein has been researched along with lysophosphatidylcholines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gómez-Fernández, JC; Hernández-Caselles, T; Villalaín, J | 1 |
| Miyahara, M; Morimoto, YM; Moromizato, Y; Okimasu, E; Sasaki, J; Shiraishi, N; Utsumi, K; Watanabe, S | 1 |
| Dordschbal, B; Roos, W; Viehweger, K | 1 |
| Aranda, FJ; Espuny, MJ; Manresa, A; Marqués, A; Ortiz, A; Sánchez, M; Teruel, JA | 1 |
| Creutz, CE; Eaton, JM; Gee, VE; Hira, JK | 1 |
| Mitchell, NJ; Pokorny, A; Seaton, P | 1 |
6 other study(ies) available for 6-carboxyfluorescein and lysophosphatidylcholines
| Article | Year |
|---|---|
Stability of liposomes on long term storage.
Topics: Chemical Phenomena; Chemistry, Physical; Chromatography, Gas; Drug Stability; Drug Storage; Fatty Acids; Fluoresceins; Linoleic Acid; Linoleic Acids; Lipid Peroxidation; Liposomes; Lysophosphatidylcholines; Phosphatidylcholines; Phospholipids; Vitamin E | 1990 |
Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Collagen; Dose-Response Relationship, Drug; Fluoresceins; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Liposomes; Lysophosphatidylcholines; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Aggregation; Pulmonary Surfactants | 1983 |
Elicitor-activated phospholipase A(2) generates lysophosphatidylcholines that mobilize the vacuolar H(+) pool for pH signaling via the activation of Na(+)-dependent proton fluxes.
Topics: Amiloride; Cell Membrane Permeability; Cells, Cultured; Enzyme Activation; Fluoresceins; Hydrogen-Ion Concentration; Lysophosphatidylcholines; Microscopy, Confocal; Papaveraceae; Phospholipases A; Phytoalexins; Plant Extracts; Sesquiterpenes; Signal Transduction; Sodium Chloride; Sodium-Hydrogen Exchangers; Terpenes; Vacuolar Proton-Translocating ATPases; Vacuoles | 2002 |
Permeabilization of biological and artificial membranes by a bacterial dirhamnolipid produced by Pseudomonas aeruginosa.
Topics: Cell Membrane; Cell Shape; Cholesterol; Erythrocytes; Fluoresceins; Glycolipids; Hemoglobins; Hemolysis; Humans; Kinetics; Lysophosphatidylcholines; Membranes, Artificial; Permeability; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Potassium; Pseudomonas aeruginosa; Unilamellar Liposomes | 2010 |
Protection of the membrane permeability barrier by annexins.
Topics: Amyloid beta-Peptides; Annexin A5; Annexin A6; Annexins; Arachidonic Acid; Calcium; Cell Membrane; Cell Membrane Permeability; Diglycerides; Fluoresceins; Humans; Islet Amyloid Polypeptide; Lipid Bilayers; Lysophosphatidylcholines; Lysophospholipids; Monoglycerides; Osmotic Pressure; Peptide Fragments; Spermidine; Unilamellar Liposomes | 2012 |
Branched phospholipids render lipid vesicles more susceptible to membrane-active peptides.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cell Membrane; Drug Compounding; Drug Liberation; Drug Resistance, Bacterial; Fluoresceins; Fluorescent Dyes; Hemolysin Proteins; Kinetics; Lipid Bilayers; Liposomes; Lysophosphatidylcholines; Myristic Acids; Phase Transition; Phosphatidylcholines; Phosphatidylglycerols; Staphylococcus; Staphylococcus aureus | 2016 |